Patents by Inventor Gavin J. Wright

Gavin J. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
    Publication number: 20180193440
    Abstract: Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.
    Type: Application
    Filed: March 5, 2018
    Publication date: July 12, 2018
    Inventors: Gavin J. WRIGHT, Julian C. RAYNER, Cecile CROSNIER, Leyla Y. BUSTAMANTE, S. Josefin BARTHOLDSON
  • IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
    Publication number: 20170087235
    Abstract: Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.
    Type: Application
    Filed: July 7, 2016
    Publication date: March 30, 2017
    Inventors: Gavin J. WRIGHT, Julian C. RAYNER, Cecile CROSNIER, Leyla Y. BUSTAMANTE, S. Josefin BARTHOLDSON
  • IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS
    Publication number: 20140093540
    Abstract: Immunogenic compositions and vaccines against Plasmodial infection comprising an Rh polypeptide or a fragment or variant thereof are disclosed. Also disclosed are Rh5 polypeptides or fragments or variants thereof capable of binding CD147 and conferring protection against infection and/or disease caused by multiple Plasmodial strains or Plasmodial species, inhibitors of the interaction between Rh5 and CD147 and methods for producing polypeptides in a mammalian expression system.
    Type: Application
    Filed: October 7, 2011
    Publication date: April 3, 2014
    Applicant: Genome Research Limited
    Inventors: Gavin J. Wright, Julian C. Rayner, Cecile Crosner, Leyla Y. Bustamante, S. Josefin Bartholdson
  • Ox2 Receptor Homologs
    Publication number: 20120231003
    Abstract: Nucleic acids encoding mammalian, e.g., primate, receptors, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
    Type: Application
    Filed: March 16, 2012
    Publication date: September 13, 2012
    Applicants: Medical Research Council, Schering Corporation
    Inventors: A. Neil Barclay, Marion H. Brown, Daniel M. Gorman, Lewis L. Lanier, Gavin J. Wright, Holly Cherwinski, Joseph H. Phillips, Robert M. Hoek, Jonathan D. Sedgwick
  • OX2 RECEPTOR HOMOLOGS
    Publication number: 20090012270
    Abstract: Nucleic acids encoding mammalian, e.g., primate, receptors, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
    Type: Application
    Filed: August 21, 2008
    Publication date: January 8, 2009
    Inventors: A. Neil BARCLAY, Marion H. Brown, Daniel M. Gorman, Lewis L. Lanier, Gavin J. Wright, Holly Cherwinski, Joseph H. Phillips, Robert M. Hoek, Jonathan D. Sedgwick